Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up

In experimental studies, mesenchymal stem cell (MSC) transplantation in acute myocardial infarction (AMI) models has been associated with enhanced neovascularization and myogenesis. Clinical data however, are scarce. Therefore, the present study evaluates the safety and feasibility of intramyocardia...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rodrigo, Sander F., van Ramshorst, Jan, Hoogslag, Georgette E., Boden, Helèn, Velders, Matthijs A., Cannegieter, Suzanne C., Roelofs, Helene, Al Younis, Imad, Dibbets-Schneider, Petra, Fibbe, Willem E., Zwaginga, Jaap Jan, Bax, Jeroen J., Schalij, Martin J., Beeres, Saskia L., Atsma, Douwe E.
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3790917/
https://ncbi.nlm.nih.gov/pubmed/23982478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-013-9507-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars